Biochemical detection of capsid in the nucleus during HIV-1 infection.
Biochemical detection of capsid in the nucleus during HIV-1 infection.
复制标题
DOI:
10.1016/j.xpro.2021.100323
复制
发表时间:
2021-03-19
期刊:
影响因子:
--
通讯作者:
Diaz-Griffero F
中科院分区:
文献类型:
--
作者:
Selyutina A;Diaz-Griffero F
To understand the role of the HIV-1 capsid in viral replication, we developed a protocol to biochemically track capsid in the nucleus during infection. To this end, we separated HIV-1-infected cells into nuclear and cytosolic fractions. Fractions were analyzed by western blotting for HIV-1 capsid content as well as for nuclear and cytosolic markers to assess the bona fide origin of the fractions. This protocol can be applied in both cycling and non-cycling human cells. For complete details on the use and execution of this protocol, please refer to. Method to track the HIV-1 capsid in the nucleus during infection in human cell lines Analysis of HIV-1 infected nuclear and cytosolic fractions The small molecule PF74 prevents entry of HIV-1 capsid into the nucleus This method can be used in cycling and non-cycling human cells To understand the role of the HIV-1 capsid in viral replication, we developed a protocol to biochemically track capsid in the nucleus during infection. To this end, we separated HIV-1-infected cells into nuclear and cytosolic fractions. Fractions were analyzed by western blotting for HIV-1 capsid content as well as for nuclear and cytosolic markers to assess the bona fide origin of the fractions. This protocol can be applied in both cycling and non-cycling human cells.